MyFinsight
Home
Blog
About
Contact
Download
Download image
Gross carrying amount
$2,300M
(-20.42%↓ Y/Y)
Cash and cash
equivalents
$7,564M
(-24.29%↓ Y/Y)
Accounts receivable, net
$4,913M
(11.15%↑ Y/Y)
Prepaid and other
current assets
$4,024M
(31.85%↑ Y/Y)
Inventories
$1,774M
(3.74%↑ Y/Y)
Short-term marketable debt
securities
$68M
Total
$14,678M
(-13.95%↓ Y/Y)
Net carrying amount
$2,300M
(-20.42%↓ Y/Y)
Total current assets
$18,342M
(-4.33%↓ Y/Y)
Intangible assets, net
$16,978M
(-14.89%↓ Y/Y)
Goodwill
$8,314M
(0.00%↑ Y/Y)
Property, plant and
equipment, net
$5,606M
(3.55%↑ Y/Y)
Other long-term
assets
$4,845M
(-21.17%↓ Y/Y)
Long-term marketable debt
securities
$2,974M
Deferred tax assets
$1,964M
Total assets
$59,023M
(0.05%↑ Y/Y)
Total liabilities and
stockholders equity
$59,023M
(0.05%↑ Y/Y)
Total stockholders
equity
$22,618M
(17.52%↑ Y/Y)
Long-term debt, net
$22,129M
(-11.11%↓ Y/Y)
Total current
liabilities
$11,813M
(-1.59%↓ Y/Y)
Other long-term
liabilities
$1,165M
(-10.04%↓ Y/Y)
Long-term income taxes
payable
$896M
(7.95%↑ Y/Y)
Deferred tax liabilities
$402M
(-44.48%↓ Y/Y)
Noncontrolling interest
-$84M
(0.00%↑ Y/Y)
Total gilead
stockholders equity
$22,703M
(17.45%↑ Y/Y)
Accrued rebates
$4,337M
(11.43%↑ Y/Y)
Other current
liabilities
$3,953M
(-27.65%↓ Y/Y)
Current portion of
long-term debt, net
$2,807M
(54.66%↑ Y/Y)
Accounts payable
$715M
(-14.17%↓ Y/Y)
Retained earnings
$13,730M
(19.42%↑ Y/Y)
Additional paid-in capital
$8,932M
(16.00%↑ Y/Y)
Accumulated other
comprehensive income
$39M
(-70.45%↓ Y/Y)
Common stock, par value
0.001 per share 5,600...
$1M
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)